StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > DISAPPOINTING

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon Apr 29, 2021 3:10pm

83 Views

Post# 33094978

RE:RE:RE:RE:RE:RE:RE:RE:DISAPPOINTING

unless care is using Aristotle now then there are no aristotle sales to date. They said no one can just get a cancer test. They need a doctor to request the test and then have a system in place to process the results and patients after. If they need to own Care before this starts then they havent sold one aristotle test yet. If Care is using the tests now then their would be sales. They have yet to update thier website that they are even tied to Stage at this time though so the chances of that are pretty slim.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1